Stratos Wealth Partners, LTD. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$215,229
-37.4%
8,010
-16.9%
0.01%
-37.5%
Q2 2023$343,584
+43.3%
9,635
+2.1%
0.01%
+33.3%
Q1 2023$239,776
-28.9%
9,440
+13.6%
0.01%
-33.3%
Q4 2022$337,054
+33.8%
8,310
+9.1%
0.01%
+28.6%
Q3 2022$252,000
-12.2%
7,620
-6.7%
0.01%0.0%
Q2 2022$287,000
-17.5%
8,165
+7.9%
0.01%
-12.5%
Q1 2022$348,000
-35.3%
7,570
-6.7%
0.01%
-33.3%
Q4 2021$538,000
-0.6%
8,115
-6.3%
0.01%
-14.3%
Q3 2021$541,000
-11.3%
8,665
+17.7%
0.01%
-6.7%
Q2 2021$610,000
+31.2%
7,365
+4.9%
0.02%
+15.4%
Q1 2021$465,000
-6.6%
7,020
+8.1%
0.01%
-13.3%
Q4 2020$498,000
+88.6%
6,495
+6.1%
0.02%
+66.7%
Q3 2020$264,000
+8.2%
6,120
+8.3%
0.01%0.0%
Q2 2020$244,000
-47.3%
5,650
-22.6%
0.01%
-50.0%
Q4 2019$463,000
+131.5%
7,300
+2.8%
0.02%
+100.0%
Q3 2019$200,000
+62.6%
7,100
+10.5%
0.01%
+80.0%
Q3 2018$123,000
+1018.2%
6,425
+328.3%
0.01%
Q1 2018$11,000
+83.3%
1,5000.0%0.00%
Q4 2017$6,0001,5000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders